Comparison of population based cancer incidence rates among circassians, chechans and Arabs in Jordan (1996-2005)

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 10, 2013, Pages 6035-6040

  Fathallah, Raja Mohd Talal ^a   Dajani, Rana ^b  

^a Center for Diabetes   (Jordan)

^b HASHEMITE UNIVERSITY   (Jordan)

Author keywords

Cancer incidence data; Chechan; Circassian; Epidemiology trends; Jordan

Indexed keywords

ARAB; ARTICLE; COMPARATIVE STUDY; ETHNIC GROUP; FEMALE; HUMAN; INCIDENCE; JORDAN; MALE; MINORITY GROUP; NEOPLASM; PROGNOSIS; REGISTER; STATISTICS;

ARABS; ETHNIC GROUPS; FEMALE; HUMANS; INCIDENCE; JORDAN; MALE; MINORITY GROUPS; NEOPLASMS; PROGNOSIS; REGISTRIES;

EID: 84890513395     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.10.6035     Document Type: Article

References (18)

1. Ajlouni K, Khader YS, Batieha A, et al (2008). An increase in prevalence of diabetes mellitus in Jordan over 10 years. J Diabetes Complicat, 22, 317-24.
2. Al-Tarawneh M, Khatib S, Arqub K (2010). Cancer incidence in Jordan, 1996-2005. Eastern Mediterranean health journal=La revue de sante de la Mediterranee orientale=al- Majallah al-sihhiyah li-sharq al-mutawassit, 16, 837-45.
3. Barbujani G, Nasidze IS, Whitehead GN (1994). Genetic diversity in the Caucasus. Hum Biol, 66, 639-68.
4. Bulayeva KB (2006). Overview of genetic-epidemiological studies in ethnically and demographically diverse isolates of dagestan, Northern Caucasus, Russia. Croat Med J, 47, 641-8.
5. Curado MP, Shin HR, Storm H, et al (2007). Cancer Incidence in five continents. IARC Scientific Publicatioins, 9.
6. Dajani R, Khader YS, Fatahallah R, et al (2012). Diabetes mellitus in genetically isolated populations in Jordan: prevalence, awareness, glycemic control, and associated factors. J Diabetes Complicat, 26, 175-80.
7. Dajani R, Khader YS, Hakooz N, et al (2013). Metabolic syndrome between two ethnic minority groups (Circassians and Chechens) and the original inhabitants of Jordan. Endocrine, 43, 112-9.
8. Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International journal of cancer. Int J Cancer, 127, 2893-917.
9. Freedman LS, Edwards BK, Ries LAG, et al (2006). Cancer incidence in four member countries (Cyprus, Egypt, Israel and Jordan) of the Middle East Conortium (MECC) compared with US SEER. (MECC Monograph) Bethesda, MAryland, NAtional Cancer Insitute (NIH Publication No. 06-5873).
10. Hawk ET, Levin B (2005). Colorectal cancer prevention. Journal of clinical oncology: official journal of the American Society of Clinical Oncology, 23, 378-91.
11. Ismail SI, Soubani M, Nimri JM, et al (2013). Cancer incidence in jordan from 1996-2009: A comprehensive study. Asian Pac J Cancer Prev, 14, 3527-34.
12. Kailani W (2002). Chechens in the Middle East: Between Original and Host Cultures. Caspian Studies Program.
13. Mahasneh AA, Abdel-Hafiz SS (2004). Polymorphism of p53 gene in Jordanian population and possible associations with breast cancer and lung adenocarcinoma. Saudi Med J, 25, 1568-73.
14. Ministry of Health. 2008. Jordan National Cancer Registry, Jordan.
15. Nasidze I, Ling EY, Quinque D, et al (2004). Mitochondrial DNA and Y-chromosome variation in the caucasus. Ann Hum Genet, 68, 205-21.
16. Rastogi T, Hildesheim A, Sinha R (2004). Opportunities for cancer epidemiology in developing countries. Nat Rev Cancer, 4, 909-17.
17. Sener SF, Grey N (2005). The global burden of cancer. J Surg Oncol, 92, 1-909-3.
18. Yang YX, Hennessy S, Lewis JD (2005). Type 2 diabetes mellitus and the risk of colorectal cancer. J Am Gastroenterol Assoc, 3, 587-94.